Related Experiment Video
Updated: May 20, 2026

Constitutive and Inducible Systems for Genetic In Vivo Modification of Mouse Hepatocytes Using Hydrodynamic Tail Vein Injection
Published on: February 2, 2018
Type II antithrombin deficiency caused by a large in-frame insertion: structural, functional and pathological
I Martínez-Martínez1, D J D Johnson, M Yamasaki
1Centro Regional de Hemodonación, University of Murcia, Regional Campus of International Excellence Campus Mare Nostrum, Murcia, Spain.
A large in-frame insertion in antithrombin (SERPINC1) caused a rare type II deficiency. This mutation resulted in a stable, non-inhibitory protein, highlighting a new mechanism for serpin-related thrombotic disorders.
Area of Science:
- Biochemistry
- Molecular Biology
- Genetics
Background:
- Serpins require a metastable native conformation for protease inhibition.
- Missense mutations can destabilize serpins, leading to protein misfolding and disease.
- Antithrombin deficiency is a genetic risk factor for thrombosis.
Purpose of the Study:
- To characterize a novel antithrombin deficiency caused by a large in-frame insertion in the SERPINC1 gene.
- Investigate the structural and functional consequences of this insertion on antithrombin function.
Main Methods:
- Functional, biochemical, and molecular analyses of the affected patient and family members.
- Expression and purification of recombinant mutant antithrombin.
- Calorimetry for stability assessment and X-ray crystallography for structural analysis.
Main Results:
- Identified a 24 bp in-frame insertion in SERPINC1, leading to type II antithrombin deficiency with impaired heparin binding.
- The mutant antithrombin was non-inhibitory, conformationally sensitive, and showed proteolytic cleavage at W49.
- Crystal structure revealed the insertion annealed into beta-sheet A, maintaining a native reactive centre loop (RCL) and a hyperstable conformation.
Conclusions:
- This is the first report of a large in-frame insertion causing a serpin deficiency.
- The mutation allows proper protein folding, glycosylation, and secretion, resulting in a stable, non-inhibitory variant.
- This finding expands the understanding of serpinopathies and their associated thrombotic risks.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis I: Introduction
Type IV Collagen of Basal Lamina
A type IV collagen molecule has six alpha chains which can exist in...
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Type II Diabetes I: Introduction

